Filter Results:
(5,623)
Show Results For
- All HBS Web
(5,623)
- People (14)
- News (1,105)
- Research (3,502)
- Events (11)
- Multimedia (22)
- Faculty Publications (2,313)
Show Results For
- All HBS Web
(5,623)
- People (14)
- News (1,105)
- Research (3,502)
- Events (11)
- Multimedia (22)
- Faculty Publications (2,313)
- March 2022 (Revised November 2024)
- Case
Aldrich Capital Partners
By: Jo Tango and Alys Ferragamo
By July 2016, the Aldrich Capital Partners team had spent over two years trying to raise their inaugural growth-equity fund. They had pitched to over 140 investors, but none had committed. Managing Partners Mirza Baig and Raz Zia each had extensive experience in the... View Details
Keywords: Growth Equity; Investment Evaluation; Entrepreneurship; Private Equity; Investment; Strategy; Decision Making; United States
Tango, Jo, and Alys Ferragamo. "Aldrich Capital Partners." Harvard Business School Case 822-090, March 2022. (Revised November 2024.)
- 16 Feb 2024
- Research & Ideas
Is Your Workplace Biased Against Introverts?
Managers almost universally say they want to see passion in their employees. Yet sometimes, they can’t spot it when it’s right in front of them. Extroverted employees are more likely to be considered passionate compared to more... View Details
Keywords: by Ben Rand
- Teaching Interest
Scaling Technology Ventures
This course is designed for students who plan to launch or join a hypergrowth technology venture, or who plan to invest in growth-stage tech companies. The course addresses key challenges founders and their teams face after achieving product-market fit – and how... View Details
- 01 Nov 2011
- First Look
First Look: Nov. 1
and teaching on risk management, we identify three categories of risk and elaborate on the ways companies can identify and mitigate them, with particular emphasis on strategy execution risks. View Details
Keywords: Sean Silverthorne
- September 2014
- Teaching Plan
Linden Lab: Crossing the Chasm
In early 2009, managers at Linden Lab, creator of the virtual world Second Life, faced decisions about the company's growth strategy. Despite profound initial skepticism about demand for a user-generated virtual world that was not a traditional game, Second Life was... View Details
Eisenmann, Thomas R. "Linden Lab: Crossing the Chasm." Harvard Business School Teaching Plan 815-053, September 2014.
- May 2014
- Case
Health Care Accountability: Examples in Cancer Treatment
By: Regina E. Herzlinger and Natalie Kindred
This case is designed to support a discussion of the importance of outcomes evidence in empowering the public to make better health care decisions, the desired level of transparency and accountability for health care providers, and the issues with current measuring and... View Details
Keywords: Accountability; Health Care; Cancer; Cancer Treatment; Memorial Sloan Kettering Cancer Center; Cancer Treatment Centers Of America; Vantage Oncology; Radiology; Risk Adjustment; Treatment Outcomes; Health Care Outcomes; Prostate Cancer; Transparency; Health Care and Treatment; Risk Management; Outcome or Result; Health Industry; United States
- April 2007
- Case
ABN AMRO Bank N.V.: Global Change Agents
By: Rosabeth M. Kanter, Lance P. Pierce and Ryan Leo Raffaelli
ABN AMRO Global Banking Group developed its risk management function in response to expansion, and increasingly focused on environmental and social risks. The head of the function needed to influence policies and business decisions in a highly decentralized context in... View Details
- 08 May 2019
- Working Paper Summaries
Bank Boards: What Has Changed Since the Financial Crisis?
- December 1970 (Revised August 1992)
- Case
Marsh & McLennan (A)
By: Paul A. Vatter
Comparison of alternative hull insurance policies. Risk analysis. Simulation suggested as solution procedures. View Details
Vatter, Paul A. "Marsh & McLennan (A)." Harvard Business School Case 171-303, December 1970. (Revised August 1992.)
- 2017
- Working Paper
Why and How Investors Use ESG Information: Evidence from a Global Survey
Using survey data from a sample of senior investment professionals from mainstream (i.e., not SRI funds) investment organizations, we provide insights into why and how investors use reported environmental, social, and governance (ESG) information. The primary reason... View Details
Keywords: Investment Management; Sustainability; ESG; ESG (Environmental, Social, Governance) Performance; Investment Fund; Investment Strategy; Corporate Accountability; Activist Shareholder; Engagement; Environment; Climate Change; Customers; Customer Satisfaction; Employee Engagement; Global Warming; Investment; Decision Making; Environmental Sustainability; Performance Expectations
Serafeim, Georgios. "Why and How Investors Use ESG Information: Evidence from a Global Survey." Harvard Business School Working Paper, No. 17-079, February 2017.
- 24 Oct 2023
- HBS Case
From P.T. Barnum to Mary Kay: Lessons From 5 Leaders Who Changed the World
are operating in competitive markets where someone is trying to leapfrog us or steal our customers,” Simons says. “The more there’s risk of disruption in your industry, the more there’s a danger that someone who is an outlier in terms of... View Details
Keywords: by Avery Forman
- 2019
- Book
The Technology Fallacy: How People Are the Real Key to Digital Transformation
By: Gerald C. Kane, Anh Phillips, Jonathan Copulsky and Garth Andrus
Digital technologies are disrupting organizations of every size and shape, leaving managers scrambling to find a technology fix that will help their organizations compete. This book offers managers and business leaders a guide for surviving digital disruptions―but it... View Details
Kane, Gerald C., Anh Phillips, Jonathan Copulsky, and Garth Andrus. The Technology Fallacy: How People Are the Real Key to Digital Transformation. Cambridge, MA: MIT Press, 2019.
- December 2005 (Revised August 2006)
- Case
Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug
By: Felix Oberholzer-Gee and Dennis A. Yao
Amgen Inc.'s Epogen was the first biotech blockbuster drug. Epogen helped prevent anemia, a condition that leads to severe fatigue, increased risk of cardiovascular disease, and even death. At the time, the market for Epogen, which included dialysis patients and... View Details
Keywords: Health Care and Treatment; Strategic Planning; Competition; Patents; Innovation and Invention; Pharmaceutical Industry; Biotechnology Industry; United States
Oberholzer-Gee, Felix, and Dennis A. Yao. "Amgen Inc.'s Epogen--Commercializing the First Biotech Blockbuster Drug." Harvard Business School Case 706-454, December 2005. (Revised August 2006.)
- 22 Mar 2018
- Blog Post
“Mission + Profit: What’s the Balance?” asks SECON 2018
How do you balance between being a mission-driven organization and a financially profitable company? That was the central question we posed to participants and speakers of this year’s Social Enterprise Conference (SECON). The 19th annual... View Details
- June 2019 (Revised October 2019)
- Technical Note
Note on the Future of Commerce
By: William R. Kerr, Daniel O'Connor and Nathaniel Schwalb
In 2019, the retail and consumer product industries were undergoing a significant transformation. Over the past 50 years, what was once a highly fragmented industry began to consolidate, digitize, and increase convenience while lowering costs. The winning enterprises... View Details
Keywords: Trade; Demand and Consumers; Demographics; Transformation; Global Range; Organizational Change and Adaptation; Business Model; Leading Change; Retail Industry; Consumer Products Industry
Kerr, William R., Daniel O'Connor, and Nathaniel Schwalb. "Note on the Future of Commerce." Harvard Business School Technical Note 819-017, June 2019. (Revised October 2019.)
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
management themes and maternal outcomes. Results: Proactive management of unit culture and nursing was associated with a significantly higher risk of primary cesarean delivery... View Details
Keywords: Sean Silverthorne
- April 2009 (Revised August 2009)
- Case
Linden Lab: Crossing the Chasm
By: Thomas R. Eisenmann and Alison Berkley Wagonfeld
In early 2008, managers at Linden Lab, creator of the virtual world Second Life, faced decisions about the company's growth strategy. Despite profound initial skepticism about demand for a user-generated virtual world that was not a traditional game, Second Life had... View Details
Keywords: Entrepreneurship; Growth and Development Strategy; Marketing Strategy; Demand and Consumers; Infrastructure; Technology Adoption; Digital Platforms
Eisenmann, Thomas R., and Alison Berkley Wagonfeld. "Linden Lab: Crossing the Chasm." Harvard Business School Case 809-147, April 2009. (Revised August 2009.)
Christopher A. Bartlett
Professor Christopher A. Bartlett received an economics degree from the University of Queensland, Australia (1964), and both the masters and doctorate degrees in business administration from Harvard University (1971 and 1979).
As a practicing manager prior... View Details
- October 2010
- Case
DLA Piper and Christie's International (A)
By: Robert G. Eccles and Dilyana Karadzhova
International law firm DLA Piper is selected as major legal services provider of renowned art business Christie's International. Nine months after the start of relationship, the client calls Nigel Knowles, DLA Piper joint CEO and Managing Partner, with a litany of... View Details